Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'sibutramine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 95 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.


    1. ASHP therapeutic position statement on the safe use of pharmacotherapy forobesity management in adults

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    2. Campbell, ML; Mathys, ML
      Pharmacologic options for the treatment of obesity

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    3. Starling, RD; Liu, XL; Sullivan, DH
      Influence of sibutramine on energy expenditure in African American women

      OBESITY RESEARCH
    4. Womble, LG; Wadden, TA; Berkowitz, RI; Sarwer, DB; Rothman, RA
      Long-term medication use and weight loss maintenance: An observational study

      OBESITY RESEARCH
    5. Arterburn, D; Noel, PH
      Extracts from "Clinical Evidence" - Obesity

      BRITISH MEDICAL JOURNAL
    6. Yip, I; Go, VLW; Hershman, JM; Wang, HJ; Elashoff, R; DeShields, S; Liu, Y; Heber, D
      Insulin-leptin-visceral fat relation during weight loss

      PANCREAS
    7. Campbell, L; Rossner, S
      Management of obesity in patients with Type 2 diabetes

      DIABETIC MEDICINE
    8. Berube-Parent, S; Prud'homme, D; St-Pierre, S; Doucet, E; Tremblay, A
      Obesity treatment with a progressive clinical tri-therapy combining sibutramine and a supervised diet-exercise intervention

      INTERNATIONAL JOURNAL OF OBESITY
    9. Fanghanel, G; Cortinas, L; Sanchez-Reyes, L; Berber, A
      Second phase of a double-blind study clinical trial on Sibutramine for thetreatment of patients suffering essential obesity: 6 months after treatment cross-over

      INTERNATIONAL JOURNAL OF OBESITY
    10. Bailey, CJ; Turner, SL; Bates, SH; Jones, RB
      Sibutramine metabolites increase glucose transport by cultured rat muscle cells

      INTERNATIONAL JOURNAL OF OBESITY
    11. Hansen, DL; Astrup, A; Toubro, S; Finer, N; Kopelman, P; Hilsted, J; Rossner, S; Saris, WHM; Van Gaal, LF; James, WPT; Goulder, M
      Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

      INTERNATIONAL JOURNAL OF OBESITY
    12. Boozer, CN; Nasser, JA; Heymsfield, SB; Wang, V; Chen, G; Solomon, JL
      An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial

      INTERNATIONAL JOURNAL OF OBESITY
    13. Prow, MR; Lancashire, B; Aspley, S; Heal, DJ; Kilpatrick, IC
      Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine

      INTERNATIONAL JOURNAL OF OBESITY
    14. Kilpatrick, IC; Traut, M; Heal, DJ
      Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release

      INTERNATIONAL JOURNAL OF OBESITY
    15. Hauner, H
      Current pharmacological approaches to the treatment of obesity

      INTERNATIONAL JOURNAL OF OBESITY
    16. Collins, P; Williams, G
      Drug treatment of obesity: from past failures to future successes?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    17. Clapham, JC; Arch, JRS; Tadayyon, M
      Anti-obesity drugs: a critical review of current therapies and future opportunities

      PHARMACOLOGY & THERAPEUTICS
    18. Smith, IG; Goulder, MA
      Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity

      JOURNAL OF FAMILY PRACTICE
    19. Brown, M; Bing, C; King, P; Pickavance, L; Heal, D; Wilding, J
      Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wister rats independently of hypothalamic neuropeptide Y

      BRITISH JOURNAL OF PHARMACOLOGY
    20. Wadden, TA; Berkowitz, RI; Sarwer, DB; Prus-Wisniewski, R; Steinberg, C
      Benefits of lifestyle modification in the pharmacologic treatment of obesity - A randomized trial

      ARCHIVES OF INTERNAL MEDICINE
    21. Scheen, AJ; Lefebvre, PJ
      Antiobesity pharmacotherapy in the management of Type 2 diabetes

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    22. Fujioka, K; Seaton, TB; Rowe, E; Jelinek, CA; Raskin, P; Lebovitz, HE; Weinstein, SP
      Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

      DIABETES OBESITY & METABOLISM
    23. Finer, N; Bloom, SR; Frost, GS; Banks, LM; Griffiths, J
      Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

      DIABETES OBESITY & METABOLISM
    24. Astrup, A
      Thermogenic drugs as a strategy for treatment of obesity

      ENDOCRINE
    25. Nakagawa, T; Ukai, K; Ohyama, T; Gomita, Y; Okamura, H
      Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: Relationship of antiobesity effect with monoamines

      EXPERIMENTAL ANIMALS
    26. Ziegler, O; Quilliot, D
      Drug therapy of obesity in type 2 diabetes mellitus.

      DIABETES & METABOLISM
    27. Wadden, TA; Berkowitz, RI; Womble, LG; Sarwer, DB; Arnold, ME; Steinberg, CM
      Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: A placebo-controlled trial

      OBESITY RESEARCH
    28. Hirsch, J; Mackintosh, RM; Aronne, LJ
      The effects of drugs used to treat obesity on the autonomic nervous system

      OBESITY RESEARCH
    29. Cuellar, GEM; Ruiz, AM; Monsalve, MCR; Berber, A
      Six-month treatment of obesity with sibutramine 15 mg; A double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

      OBESITY RESEARCH
    30. Bray, GA
      A concise review on the therapeutics of obesity

      NUTRITION
    31. Greenway, FL; Smith, SR
      The future of obesity research

      NUTRITION
    32. Rowley, HL; Butler, S; Prow, MR; Dykes, SG; Aspley, S; Kilpatrick, IC; Heal, DJ
      Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats

      SYNAPSE
    33. Wilding, J
      Obesity and Type 2 diabetes mellitus

      DIABETIC MEDICINE
    34. Radhakrishna, T; Narayana, CL; Rao, DS; Vyas, K; Reddy, GO
      LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    35. Fanghanel, G; Cortinas, L; Sanchez-Reyes, L; Berber, A
      A clinical trial of the use of Sibutramine for the treatment of patients suffering essential obesity

      INTERNATIONAL JOURNAL OF OBESITY
    36. Fabris, R; Granzotto, M; Pagano, C; Lombardi, AM; Ferretti, E; Marzolo, M; Scagnol, I; Federspil, G; Vettor, R
      Effect of sibutramine on glucose metabolism in genetically obese (fa/fa) Zucker rats

      INTERNATIONAL JOURNAL OF OBESITY
    37. Wesnes, KA; Garratt, C; Wickens, M; Gudgeon, A; Oliver, S
      Effects of sibutramine alone and with alcohol on cognitive function in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    38. Rothman, RB; Carroll, FI
      Opportunities for medication development in obesity

      DRUG DEVELOPMENT RESEARCH
    39. Ryan, DH
      Recent progress in obesity pharmacotherapy

      CURRENT OPINION IN GASTROENTEROLOGY
    40. Agrawal, M; Worzniak, M; Diamond, L
      Managing obesity like any other chronic condition - Long-term therapy may reduce comorbidity as well

      POSTGRADUATE MEDICINE
    41. Mattes, RD; Bormann, L
      Effects of (-)-hydroxycitric acid on appetitive variables

      PHYSIOLOGY & BEHAVIOR
    42. Chapelot, D; Marmonier, C; Thomas, F; Hanotin, C
      Modalities of the food intake-reducing effect of sibutramine in humans

      PHYSIOLOGY & BEHAVIOR
    43. Balcioglu, A; Wurtman, RJ
      Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid

      NEUROPHARMACOLOGY
    44. Cheetham, SC; Viggers, JA; Slater, NA; Heal, DJ
      Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine

      NEUROPHARMACOLOGY

    45. SEEDO ' 2000 consensus for the evaluation of overweight and obesity and the assessment of obesity management

      MEDICINA CLINICA
    46. Hensrud, DD
      Pharmacotherapy for obesity

      MEDICAL CLINICS OF NORTH AMERICA
    47. Trent, ME; Laufer, MR
      Obesity in adolescent girls - Emerging role of reproductive health professionals

      JOURNAL OF REPRODUCTIVE MEDICINE
    48. Glick, SD; Haskew, RE; Maisonneuve, IM; Carlson, JN; Jerussi, TP
      Enantioselective behavioral effects of sibutramine metabolites

      EUROPEAN JOURNAL OF PHARMACOLOGY
    49. Hazenberg, BP
      Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients

      CARDIOLOGY
    50. Lean, MEJ
      Is long-term weight loss possible?

      BRITISH JOURNAL OF NUTRITION
    51. Berke, EM; Morden, NE
      Medical management of obesity

      AMERICAN FAMILY PHYSICIAN
    52. Poston, WSC; Foreyt, JP
      Successful management of the obese patient

      AMERICAN FAMILY PHYSICIAN
    53. Rowland, NE; Marshall, M; Roth, JD
      Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats

      PSYCHOPHARMACOLOGY
    54. Schuh, LM; Schuster, CR; Hopper, JA; Mendel, CM
      Abase liability assessment of sibutramine, a novel weight control agent

      PSYCHOPHARMACOLOGY
    55. Ellrott, T
      Current efforts in the drug treatment of obesity

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    56. Leong, KS; Wilding, JP
      Obesity and diabetes

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    57. Bray, GA
      Drug treatment of obesity

      BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
    58. Tremblay, A; Doucet, E; Imbeault, P; Mauriege, P; Despres, JP; Richard, D
      Metabolic fitness in active reduced-obese individuals

      OBESITY RESEARCH
    59. Bray, GA
      Uses and misuses of the new pharmacotherapy of obesity

      ANNALS OF MEDICINE
    60. Walsh, KM; Leen, E; Lean, MEJ
      The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females

      INTERNATIONAL JOURNAL OF OBESITY
    61. Hansen, DL; Toubro, S; Stock, MJ; Macdonald, IA; Astrup, A
      The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

      INTERNATIONAL JOURNAL OF OBESITY
    62. Greenberg, I; Chan, S; Blackburn, GL
      Nonpharmacologic and pharmacologic management of weight gain

      JOURNAL OF CLINICAL PSYCHIATRY
    63. Hind, ID; Mangham, JE; Ghani, SP; Haddock, RE; Garratt, CJ; Jones, RW
      Sibutramine pharmacokinetics in young and elderly healthy subjects

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    64. Berg, FM
      Health risks associated with weight loss and obesity treatment programs

      JOURNAL OF SOCIAL ISSUES
    65. Gray, AM; Pache, DM; Sewell, RDE
      Do alpha(2)-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?

      EUROPEAN JOURNAL OF PHARMACOLOGY
    66. Wortley, KE; Heal, DJ; Stanford, SC
      Modulation of sibutramine-induced increases in extracellular noradrenalineconcentration in rat frontal cortex and hypothalamus by alpha(2)-adrenoceptors

      BRITISH JOURNAL OF PHARMACOLOGY
    67. Wortley, KE; Hughes, ZA; Heal, DJ; Stanford, SC
      Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha(2)-adrenoceptors

      BRITISH JOURNAL OF PHARMACOLOGY
    68. Grignaschi, G; Fanelli, E; Scagnol, I; Samanin, R
      Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats

      BRITISH JOURNAL OF PHARMACOLOGY
    69. Connoley, IP; Liu, YL; Frost, I; Reckless, IP; Heal, DJ; Stock, MJ
      Thermogenic effects of sibutramine and its metabolites

      BRITISH JOURNAL OF PHARMACOLOGY
    70. Van Gaal, LF; Peiffer, FW; De Leeuw, IH
      New pharmacological directions for the treatment of overweight and obesity

      ACTA CLINICA BELGICA
    71. SEAGLE HM; BESSESEN DH; HILL JO
      EFFECTS OF SIBUTRAMINE ON RESTING METABOLIC-RATE AND WEIGHT-LOSS IN OVERWEIGHT WOMEN

      Obesity research
    72. ROLLS BJ; SHIDE DJ; THORWART ML; ULBRECHT JS
      SIBUTRAMINE REDUCES FOOD-INTAKE IN NON-DIETING WOMEN WITH OBESITY

      Obesity research
    73. ATKINSON RL
      GUIDELINES FOR THE INITIATION OF OBESITY TREATMENT

      Journal of nutritional biochemistry
    74. VANGAAL LF; WAUTERS MA; DELEEUW IH
      ANTIOBESITY DRUGS - WHAT DOES SIBUTRAMINE OFFER - AN ANALYSIS OF ITS POTENTIAL CONTRIBUTION TO OBESITY TREATMENT

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    75. DAY C; BAILEY CJ
      EFFECT OF THE ANTIOBESITY AGENT SIBUTRAMINE IN OBESE-DIABETIC OB OB MICE/

      International journal of obesity
    76. HANOTIN C; THOMAS F; JONES SP; LEUTENEGGER E; DROUIN P
      EFFICACY AND TOLERABILITY OF SIBUTRAMINE IN OBESE PATIENTS - A DOSE-RANGING STUDY

      International journal of obesity
    77. HEAL DJ; ASPLEY S; PROW MR; JACKSON HC; MARTIN KF; CHEETHAM SC
      SIBUTRAMINE - A NOVEL ANTIOBESITY DRUG - A REVIEW OF THE PHARMACOLOGICAL EVIDENCE TO DIFFERENTIATE IT FROM D-AMPHETAMINE AND D-FENFLURAMINE

      International journal of obesity
    78. ASTRUP A; HANSEN DL; LUNDSGAARD C; TOUBRO S
      SIBUTRAMINE AND ENERGY-BALANCE

      International journal of obesity
    79. VANGAAL LF; WAUTERS MA; PEIFFER FW; DELEEUW IH
      SIBUTRAMINE AND FAT DISTRIBUTION - IS THERE A ROLE FOR PHARMACOTHERAPY IN ABDOMINAL VISCERAL FAT REDUCTION/

      International journal of obesity
    80. Astrup, A
      Sibutramine, a forthcoming drug, induces weight loss by reduction of energy intake and increase of energy expenditure

      ACTA MEDICA AUSTRIACA
    81. HALFORD JCG; WANNINAYAKE SCD; BLUNDELL JE
      BEHAVIORAL SATIETY SEQUENCE (BSS) FOR THE DIAGNOSIS OF DRUG-ACTION ONFOOD-INTAKE

      Pharmacology, biochemistry and behavior
    82. McNeely, W; Goa, KL
      Sibutramine - A review of its contribution to the management of obesity

      DRUGS
    83. HEAL DJ; CHEETHAM SC; PROW MR; MARTIN KF; BUCKETT WR
      A COMPARISON OF THE EFFECTS ON CENTRAL 5-HT FUNCTION OF SIBUTRAMINE HYDROCHLORIDE AND OTHER WEIGHT-MODIFYING AGENTS

      British Journal of Pharmacology
    84. JACKSON HC; CHEETHAM SC; GOSDEN J; HUTCHINS LJ; KERRIGAN F; NEEDHAM AM; PLEASANCE IM; SARGENT BJ; HEAL DJ
      BEHAVIORAL-EFFECTS OF THE MONOAMINE REUPTAKE INHIBITOR, BTS-74398, INRATS AND MICE

      British Journal of Pharmacology
    85. Hansen, DL; Toubro, S; Stock, MJ; Macdonald, IA; Astrup, A
      Thermogenic effects of sibutramine in humans

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    86. LEAN MEJ
      SIBUTRAMINE - A REVIEW OF CLINICAL EFFICACY

      International journal of obesity
    87. JACKSON HC; BEARHAM MC; HUTCHINS LJ; MAZURKIEWICZ SE; NEEDHAM AM; HEAL DJ
      INVESTIGATION OF THE MECHANISMS UNDERLYING THE HYPOPHAGIC EFFECTS OF THE 5-HT AND NORADRENALINE REUPTAKE INHIBITOR, SIBUTRAMINE, IN THE RAT

      British Journal of Pharmacology
    88. JACKSON HC; NEEDHAM AM; HUTCHINS LJ; MAZURKIEWICZ SE; HEAL DJ
      COMPARISON OF THE EFFECTS OF SIBUTRAMINE AND OTHER MONOAMINE REUPTAKEINHIBITORS ON FOOD-INTAKE IN RAT THE

      British Journal of Pharmacology
    89. CHEETHAM SC; VIGGERS JA; BUTLER SA; PROW MR; HEAL DJ
      [H-3] NISOXETINE - A RADIOLIGAND FOR NORADRENALINE REUPTAKE SITES - CORRELATION WITH INHIBITION OF [H-3] NORADRENALINE UPTAKE AND EFFECT OFDSP-4 LESIONING AND ANTIDEPRESSANT TREATMENTS

      Neuropharmacology
    90. BLUNDELL JE; HALFORD JCG
      PHARMACOLOGICAL ASPECTS OF OBESITY TREATMENT - TOWARDS THE 21ST-CENTURY

      International journal of obesity
    91. MARTIN KF; PHILLIPS I; CHEETHAM SC; HEAL DJ
      DOPAMINE D-2 RECEPTORS - A POTENTIAL PHARMACOLOGICAL TARGET FOR NOMIFENSINE AND TRANYLCYPROMINE BUT NOT OTHER ANTIDEPRESSANT TREATMENTS

      Pharmacology, biochemistry and behavior
    92. OGILVIE J; CHEETHAM SC; GOSDEN J; BUTLER SA; HEAL DJ
      EVIDENCE THAT OPIOIDS ARE NOT INVOLVED IN THE DOWN-REGULATION OF CENTRAL BETA-1-ADRENOCEPTORS AND ALPHA-2-ADRENOCEPTORS BY SIMULATED ELECTROCONVULSIVE-THERAPY

      British Journal of Pharmacology
    93. DAVIS S; HEAL DJ; STANFORD SC
      LONG-LASTING EFFECTS OF AN ACUTE STRESS ON THE NEUROCHEMISTRY AND FUNCTION OF 5-HYDROXYTRYPTAMINERGIC NEURONS IN THE MOUSE-BRAIN

      Psychopharmacology
    94. SCOTT G; LUSCOMBE GP; MASON R
      THE EFFECTS OF BTS-54-505, A METABOLITE OF SIBUTRAMINE, ON MONOAMINE AND EXCITATORY AMINO ACID-EVOKED RESPONSES IN THE RAT DORSOLATERAL GENICULATE-NUCLEUS IN-VIVO

      British Journal of Pharmacology
    95. CHEETHAM SC; VIGGERS JA; SLATER NA; HEAL DJ; BUCKETT WR
      H-3! PAROXETINE BINDING IN RAT FRONTAL-CORTEX STRONGLY CORRELATES WITH H-3! 5-HT UPTAKE - EFFECT OF ADMINISTRATION OF VARIOUS ANTIDEPRESSANT TREATMENTS

      Neuropharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 22:55:23